[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100161324":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":35,"collaborators":10,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":44,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":56,"overallStatus":19,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Xijing Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"volunteer",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Ling Tao, M.D Ph.D","CONTACT","+86-15002955798","lingtao2006@gmail.com",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Xi'an","Shaanxi","710032","China","CN",{"type":26,"coordinates":27},"Point",[28,29],108.92861,34.25833,{"lat":29,"lon":28},[32,33],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"name":13,"role":34,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":36,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100161324","serum-adiponectin-in-chinese-population-and-its-correlation-to-cardiovascular-and-cerebrovascular-diseases-100161324",false,"NCT01372800","Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases","Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases","Inclusion Criteria:\n\n* available for 5 years of follow-up study\n\nExclusion Criteria:\n\n* Death caused other than cardiovascular and cerebralvascular diseases till the study ends\n* Floating Population\n* Pregnancy, lactation, or child bearing women\n* Tumor\n* Active hepatic disease or hepatic dysfunction, or AST\u002FALT \\> 1.5UNL\n* Severe renal dysfunction(Scr \\> 3 mg\u002Fdl or 264μmol\u002FL)\n* Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding",true,"ALL","18 Years","85 Years",{"count":49,"type":50},30000,"ESTIMATED","OBSERVATIONAL","Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.",[54,55],"Myocardial Infarction","Cerebral Infarction",[57,58,59],"adiponectin","cardiovascular diseases","cerebrovascular diseases","2025-02-04",{"date":62,"type":63},"2025-02-07","ACTUAL",{"date":65,"type":63},"2011-05-01",{"date":67,"type":50},"2036-10-01",{"name":5,"class":6},1]